ClinicalTrials.Veeva

Menu

Growth and Tolerance of Infants Fed Formula for 16 Weeks

N

Nature's One

Status

Completed

Conditions

Child Development

Treatments

Other: Infant formula

Study type

Interventional

Funder types

Industry

Identifiers

NCT03487094
N1.2018

Details and patient eligibility

About

Growth and Tolerance Trial of Iron-fortified infant formulas

Full description

16 WEEK GROWTH AND TOLERANCE

Enrollment

216 patients

Sex

All

Ages

1 to 14 days old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy term infants, 37-42 weeks gestational age

Exclusion criteria

  • Any condition that would negatively impact assessment of growth and tolerance

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

216 participants in 2 patient groups

Growth, Tolerance of Infants-Exp
Active Comparator group
Description:
Infant Formula
Treatment:
Other: Infant formula
Growth,Tolerance of Infants-Com
Active Comparator group
Description:
Infant Formula
Treatment:
Other: Infant formula

Trial contacts and locations

24

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems